CMB 1.27% 39.0¢ cambium bio limited

Bang, bang.From inflammation to pain treatment, RGS, through its...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 173 Posts.
    lightbulb Created with Sketch. 53
    Bang, bang.
    From inflammation to pain treatment, RGS, through its Progenza platform, now holds multiple patents in Japan for the use of Mesenchymal Stem Cells.
    Then, Sygenus will be added, for the use of stem cells secretions.
    Very good news. This will only strengthen Kyocera's commercial position in the Japanese market.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.